dr. overman on next steps with immunotherapy in mcrc
Published 5 years ago • 251 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:18
dr. overman on unmet needs with immunotherapy in mcrc
-
1:00
dr. lenz on next steps with immunotherapy in mcrc
-
1:46
dr. overman on investigational targeted therapies in mcrc
-
1:42
dr. overman on the impact of nivolumab in mcrc
-
1:38
dr. overman on remaining questions with immunotherapy in crc
-
1:27
dr. overman on ongoing research with immunotherapy in mss crc
-
1:31
dr. michael j. overman on immunotherapy in colorectal cancer
-
1:03
dr. overman on implications of tumor location data for patients with mcrc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
2:15
dr. overman discusses redos study in mcrc
-
1:15
dr. overman discusses progress with immunotherapy in gi cancer
-
1:35
dr. lockhart on next steps for regorafenib and tas-102 in mcrc
-
1:29
dr. overman on tailoring approaches to molecular subsets in mcrc
-
1:07
dr. bendell on the next steps following progression on immunotherapy in msi-h crc
-
1:09
dr. overman on second-line therapy options for colorectal cancer
-
2:32
dr. overman discusses updated findings of checkmate-142 in patients with msi-h mcrc
-
1:08
dr. overman discusses nivolumab in patients with dmmr/msi h mcrc
-
2:00
dr. overman on nivolumab and ipilimumab in patients with msi-h crc
-
1:58
dr. kasi on role of immunotherapy in mcrc